Overview

Nigella 5 in the Treatment of SARS COV2 (COVID-19)

Status:
Recruiting
Trial end date:
2021-11-30
Target enrollment:
Participant gender:
Summary
The world is currently facing a crisis because of this potentially fatal situation of the COVID-19 epidemic without proven efficacy for any drug treatment, while the vaccination is not yet. This epidemic is caused by a new betacorona virus, now called SARS-CoV-2. The most common symptoms reported are fever, cough or chest tightness, and dyspnea. Most cases have a mild course
Phase:
Phase 1
Details
Lead Sponsor:
Hôpital Universitaire Sahloul